OPNT - Opiant Pharmaceuticals Inc. (OPNT) CEO Roger Crystal on Q3 2021 Results - Earnings Call Transcript

Opiant Pharmaceuticals, Inc. (OPNT) Q3 2021 Earnings Conference Call November 11, 2021 4:30 PM ET Company Participants Ben Atkins - Vice President, Communications and Investor Relations Roger Crystal - President and Chief Executive Officer Matt Ruth - Chief Commercial Officer David O'Toole - Chief Financial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Carl Byrnes - Northland Capital Markets David Bautz - Zacks Small Cap Research Mark Walsh - Private Investor Presentation Operator Good day, ladies and gentlemen and welcome to the Opiant Pharmaceuticals Third Quarter 2021 Financial Results and Business Update Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] I would now like to turn the call over to your host Ben Atkins, Vice President, Communications and Investor Relations of Opiant Pharmaceuticals. Please go ahead. Ben Atkins Thank you, operator, and thank you all

For further details see:

Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q3 2021 Results - Earnings Call Transcript